期刊文献+

DNA损伤修复蛋白XPF影响肾癌细胞顺铂耐药 被引量:2

DNA repair protein XPF affects cisplatin resistance of renal cancer cells
下载PDF
导出
摘要 目的探索DNA损伤修复蛋白XPF表达水平影响肾癌细胞顺铂耐药的作用与机制。方法 Western blot法检测不同肾癌细胞株的XPF蛋白水平;采用shRNA干扰技术,筛选稳定低表达XPF的细胞株;采用克隆形成实验及细胞凋亡检测实验,比较XPF低表达细胞株与XPF正常表达细胞株的顺铂敏感性;通过β-半乳糖苷酶染色法,检测细胞的衰老程度。结果在肾癌细胞786-0、ACHN和Caki-1中,ACHN细胞的XPF表达水平最高,其顺铂耐药程度也最高。shRNA干扰获得稳定低表达XPF的ACHN细胞,顺铂处理后,其克隆形成率低于对照(P<0.05),细胞凋亡率高于对照,衰老细胞比例也显著高于对照(P<0.01)。结论肾癌化疗不敏感可能与其高表达DNA损伤修复蛋白XPF有关,干预并下调肾癌ACHN细胞XPF表达,可增强顺铂的凋亡诱导效应并加速衰老,从而提高其顺铂敏感性。 Objective To investigate the role and the underlying mechanism of the expression of DNA damage repair protein XPF in cisplatin resistance of renal cancer cells. Methods XPF level in different renal cancer cell lines ACHN, 786-0 and Caki-1 was detected by Western blotting. After acquiring shXPF cells with XPF expression stably inhibited to a low level by shRNA technique, cisplatin resistance was detected in the shXPF cells and shNC cells (negative control) by colony formation assay and Annexin V-FITC/PI staining. β-galactosidase staining was used to detect cell senescence of shXPF cells. Results Among 786-0 cells, ACHN cells and Caki-1 cells, XPF was strongly expressed in ACHN cells, which showed highest resistance to cisplatin. After interfered by shRNA technique, ACHN-shXPF cells were acquired stably expressing lower level XPF, showing lower colony formation rate (P〈0.05) and higher percentage of apoptosis after cisplatin treatment. Additionally, the percentage of senescent cells was significantly higher in ACHN-shXPF than ACHN-shNC cells (P〈0.01). Conclusion The insensitivity of renal cancer cells to cisplatin might be related with the high expression of DNA damage repair protein XPF. Interfering the XPF expression in ACHN cells can promote cisplatin-induced apoptosis and cell aging, thus leading to higher sensitivity to cisplatin.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2014年第9期852-855,共4页 Journal of Third Military Medical University
基金 国家自然科学基金面上项目(81272822) 第三军医大学临床医学研究重大专项基金项目(2012XLC02)~~
关键词 肾癌 顺铂 XPF 细胞衰老 renal cancer cisplatin XPF cell aging
  • 相关文献

参考文献11

  • 1Breier A, Gibalova L, Seres M, et al. New insight into p-glycoprotein as a drug target [ J ]. Anticancer Agents Med Chem, 2013, 13 ( 1 ) : 159 - 170.
  • 2Martin L P, Hamilton T C, Schilder R J. Platinum resistance : the role of DNA repair pathways[J]. Clin Cancer Res, 2008, 14(5) : ]291 - 1295.
  • 3Galluzzi L, Senovilla L, Vitale I, et al. Molecular mechanisms of cis- platin resistance[J]. Oneogene, 2012, 31 (15) : 1869 - 1883.
  • 4Wood D P. Re: Cisplatin Sensitivity of Testis Tumour Cells is Due to Deficiency in Interstrand-Crosslink Repair and Low ERCCI-XPF Ex- pression Editorial Comment[Jl. J of Urol, 2011 , 186(2) : 457.
  • 5Usanova S, Piee-St'M'fa A, Sied U, et al. Cisplatin sensitivity of testis turnout cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression [ J ]. Mol Cancer, 2010, 9 : 248.
  • 6Enoiu M, Jiricny J, Scharer O D. Repair of cisplatin-induced DNA in- terstrand crosslinks by a replication-independent pathway involving transcription-coupled repair and translesion synthesis [ J ]. Nucleic Acids Res, 2012, 40(18) : 8953 -8964.
  • 7McNeil E M, Melton D W. DNA repair endonuelease ERCCl-XPF as a novel therapeutic target to overcome chemoresistance in cancer therapy [J]. Nucleic Acids Res, 2012, 40(20) : 9990 - 10004.
  • 8Arora S, Kothandapani A, Tillison K, et al. Downregulation of XPF- ERCC1 enhances cisplatin efficacy in cancer cells [ J ]. DNA Repair (Amst) , 2010, 9(7): 745-753.
  • 9Signer R A, Morrison S J. Mechanisms that regulate stem cell aging and life span[J]. Cell Stem Cell, 2013, 12(2) : 152 -465.
  • 10Weeda G, Donker I, de-Wit J, et al. Disruption of mouse ERCC1 re- suits in a novel repair syndrome with growth failure, nuclear abnor- malities and senescence[J]. Curt Biol, 1997, 7(6) : 427 -439.

同被引文献23

  • 1Crowley E,Di Nicolantonio F,Loupakis F,et al.Liquid biopsy:monitoring cancer-genetics in the blood[J].Nat Rev Clin Oncol,2013,10(8):472.
  • 2Mandel P,Metais P.Les acides nucleiques du plasma sanguin chez l'homme[J].CR Acad Sci Paris,1948,142(3/4):241.
  • 3Stroun M,Anker P,Maurice P,et al.Neoplastic characteristics of the DNA found in the plasma of cancer patients[J].Oncology,1989,46(5):318.
  • 4Umetani N,Giuliano A E,Hiramatsu S H,et al.Prediction of breast tumor progression by integrity of free circulating DNA in serum[J].J Clin Oncol,2006,4(26):4270.
  • 5Jahr S,Hentze H,Englisch S,et al.DNA fragments in the blood plasma of cancer patients:quantitations and evidence for their origin from apoptotic and necrotic cells[J].Cancer Res,2001,1(4):1659.
  • 6Diehl F,Li M,Dressman D,et al.Detection and quantification of mutations in the plasma of patients with colorectal tumors[J].Proc Natl Acad Sci USA,2005,102(45):16368.
  • 7Umetani N,Kim J,Hiramatsu S,et al.Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer:direct quantitative PCR for ALU repeats[J].Clin Chem,2006,2(6):1062.
  • 8El-Shazly S F,Eid M A,El-Sourogy H A,et al.Evaluation of serum DNA integrity as a screening and prognostic tool in patients with hepatitis C virus-related hepatocellular carcinoma[J].Int J Biol Markers,2010,5(2):79.
  • 9Galluzzi I., Senovilla L, Vitale nisms of cisplatin resistanee[J] 1869-1883. 1, et al . Molecular mecha Oncogene, 2012, 31 (15).
  • 10Borst P, Rottenberg S, Jonkers J. How do real tumors be- come resistant to cisplatin~J]? Cell Cycle, 2008 ,7(10) :1353 1359.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部